Showing results (1-10 of 177) with videos related to
Sort By:
Pageof 18
The Journal of Pharmacy and Pharmacology|September 25, 2008
An evaluation of the relative roles of the unstirred water layer and receptor sink in limiting the in-vitro intestinal permeability of drug compounds of varying lipophilicityKasiram Katneni, Susan A Charman, Christopher J H PorterJournal of Pharmaceutical Sciences|October 20, 2006
Impact of cremophor-EL and polysorbate-80 on digoxin permeability across rat jejunum: delineation of thermodynamic and transporter related events using the reciprocal permeability approachKasiram Katneni, Susan A Charman, Christopher J H PorterJournal of Pharmaceutical Sciences|June 23, 2007
Use of plasma proteins as solubilizing agents in in vitro permeability experiments: correction for unbound drug concentration using the reciprocal permeability approachKasiram Katneni, Susan A Charman, Christopher J H PorterJournal of Pharmaceutical Sciences|August 3, 2006
Permeability assessment of poorly water-soluble compounds under solubilizing conditions: the reciprocal permeability approachKasiram Katneni, Susan A Charman, Christopher J H PorterThe Journal of Pharmacy and Pharmacology|March 16, 2006
Methods to assess drug permeability across the blood-brain barrierJoseph A Nicolazzo, Susan A Charman, William N CharmanPharmaceutical Research|June 30, 2012
Computational prediction of CNS drug exposure based on a novel in vivo datasetChristel A S Bergström, Susan A Charman, Joseph A NicolazzoDrug Discovery Today. Technologies|July 2, 2014
Subcutaneous drug delivery and the role of the lymphaticsDanielle N McLennan, Christopher J H Porter, Susan A CharmanThe Journal of Antimicrobial Chemotherapy|June 1, 2006
In vitro assessment of the pharmacodynamic properties and the partitioning of OZ277/RBx-11160 in cultures of Plasmodium falciparumSonja Maerki, Reto Brun, Susan A Charman, et al.Antimicrobial Agents and Chemotherapy|December 22, 2017
Parasite-Mediated Degradation of Synthetic Ozonide Antimalarials Impacts <i>In Vitro</i> Antimalarial ActivityCarlo Giannangelo, Lukas Stingelin, Tuo Yang, et al.Biopharmaceutics & Drug Disposition|September 25, 2010
Preclinical comparison of intravenous melphalan pharmacokinetics administered in formulations containing either (SBE)7 m-β-cyclodextrin or a co-solvent systemMaria Koltun, Julia Morizzi, Kasiram Katneni, et al.Pageof 18